Alnylam Pharmaceuticals, Inc. (ALNY)

Alnylam Pharmaceuticals Market Cap

Alnylam Pharmaceuticals has a market cap or net worth of $35.71 billion as of July 17, 2026. Its market cap has decreased by -15.16% in one year.

• Market Cap: 35.71B
• Enterprise Value: 35.88B
• 1-Year Change: -15.16%
• Ranking: #400
• Category: Large-Cap
• Stock Price: $267.47

Market Cap Chart

Chart

Since June 1, 2004, Alnylam Pharmaceuticals's market cap has increased from $135.00M to $35.71B, an increase of 26,352.30%. That is a compound annual growth rate of 28.65%.

Market Cap History

Date	Market Cap	% Change
Jul 17, 2026	35.71B	-32.03%
Dec 31, 2025	52.54B	73.09%
Dec 31, 2024	30.35B	26.35%
Dec 29, 2023	24.02B	-17.84%
Dec 30, 2022	29.24B	44.16%
Dec 31, 2021	20.28B	34.32%
Dec 31, 2020	15.10B	17.60%
Dec 31, 2019	12.84B	74.32%
Dec 31, 2018	7.37B	-37.48%
Dec 29, 2017	11.78B	266.69%
Dec 30, 2016	3.21B	-59.72%
Dec 31, 2015	7.98B	6.90%
Dec 31, 2014	7.46B	82.96%
Dec 31, 2013	4.08B	326.36%
Dec 31, 2012	956.60M	174.73%
Dec 30, 2011	348.20M	-16.32%
Dec 31, 2010	416.10M	-43.53%
Dec 31, 2009	736.80M	-28.05%
Dec 31, 2008	1.02B	-13.48%
Dec 31, 2007	1.18B	71.64%
Dec 29, 2006	689.60M	94.42%
Dec 30, 2005	354.70M	136.47%
Dec 31, 2004	150.00M	11.11%
Jun 1, 2004	135.00M	-

View and export this data all the way back to 2004. Sign Up Today.

Data Source: Nasdaq Data Link Last updated: Jul 16, 2026

Market cap data is provided by Nasdaq Data Link. The current market cap updates continuously throughout the trading day, while the historical market cap is updated daily after market close.

Update frequency:

Daily

Last checked:

Jul 17, 2026

Data Sources Report a data error

Related Stocks

Company	Market Cap
Regeneron Pharmaceuticals	67.60B
argenx SE	53.71B
Revolution Medicines	39.21B
BeOne Medicines AG	34.60B
Royalty Pharma	32.43B
Moderna	27.09B
Roivant Sciences	25.10B
Insmed	23.80B